Tamiflu reduces risk of death by 25 percent in adults hospitalised with H1N1 pandemic influenza

March 18, 2014

Adults hospitalised with H1N1 influenza during the 2009-2010 pandemic were 25% less likely to die from the disease if they were given antiviral drugs called neuraminidase inhibitors (NAIs) such as Tamiflu, according to a large meta-analysis involving more than 29 000 patients from 38 countries, published in The Lancet Respiratory Medicine journal. The findings also indicate that treatment within 2 days of flu symptoms developing halved the risk of death compared with later treatment or no treatment.

"Many governments have stockpiles of Tamiflu that are close to expiry. But until now, they had no adequate data to assist them in deciding if lives were saved in 2009-2010 or not, and whether they should replenish or not", explains lead author Professor Jonathan Nguyen-Van-Tam, from the University of Nottingham in the UK.

"The situation is made more complex by the fact that when an influenza occurs, even with the best will in the world, vaccine arrives six months too late and its public health benefit is therefore moderate at best. Thus we are left with antivirals like Tamiflu and public health measures like handwashing and social distancing as the only defences we have for the first 6 months of a pandemic."

Nguyen-Van-Tam, and colleagues from the Post-pandemic Review of anti-Influenza Drug Effectiveness (PRIDE) research consortium, did a meta-analysis of individual patient data to assess the effects of NAI treatment (primarily Tamiflu) on death in patients hospitalised with confirmed or suspected H1N1 infection between January 2, 2009 and March 14, 2011. Using statistical modelling, the researchers compensated for the effects of treatment propensity (likelihood of treatment) as well as other confounding factors such as treatment with corticosteroids and antibiotics and health-care seeking behaviour.

Analysis of data from 78 studies involving 29 234 patients of all ages revealed that treatment with NAIs (at any time) reduced the risk of death by 19%, compared with no treatment.

The researchers report that to maximise survival, ideally NAIs should be started within 2 days of symptoms developing. The risk of death was halved when starting treatment within 48 hours of compared with later treatment, or no . Each day that starting antiviral treatment was delayed after 2 days from illness onset was associated with about a 20% increase in the risk of death compared with treatment started within 2 days.

Importantly, they noted much the same survival benefit in pregnant women and adult patients in intensive care with more severe symptoms, but observed no significant mortality reduction in children.

According to Professor Nguyen-Van-Tam, "Since placebo-controlled trials of NAIs are not ethically feasible during a pandemic, the evidence we have assembled is likely to be the best that is available. Our data suggest that in line with US Centers for Disease Control and Prevention recommendations, treatment guidance policies should emphasise that NAI treatment should be started as soon as possible for any hospitalised adult who presents with influenza that is suspected or confirmed. Since so many patients with severe influenza are not admitted to hospital within 48 hours of symptom onset, the same applies to in the community who are appreciably unwell with influenza like illness or who have underlying risk conditions. If clinical suspicion is high, one should not wait for laboratory confirmation before starting treatment."

Writing in a linked Comment, Alicia Fry from the Centers for Disease Control and Prevention in the USA says, "As expected, early treatment seems to be optimal, and treatment shouldn't be delayed by even 1 day to wait for diagnostic test results; however, if the patient presents for care more than 2 days after illness onset, treatment might still have some benefit, especially if they are severely ill. Although additional evidence for the benefits of NAI treatment in children admitted to hospital, and how to optimise treatment, are needed, in the absence of any other influenza-specific treatment, the potential benefit from NAI treatment for severely ill children is substantial and outweighs any potential risk associated with treatment."

She concludes, "Continuing efforts to identify other anti-influenza options, especially those with different virus targets or mechanisms of action, might improve our ability to care for severely ill patients with influenza and reduce the risk of mortality further."

Explore further: Kids hospitalized for flu need antiviral meds right away: study

Related Stories

Kids hospitalized for flu need antiviral meds right away: study

November 25, 2013
(HealthDay)—Kids near death because of severe flu infection have a better chance of survival if they are given antiviral medications early in their treatment, researchers say.

CDC: Influenza activity increasing across the U.S.

January 5, 2013
(HealthDay)—Flu season descended on the United States early and hard this winter, with significant increases in flu activity observed over the past month, according to an update issued Jan. 4 by the U.S. Centers for Disease ...

Young, unvaccinated adults account for severest flu cases

February 10, 2014
A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.

Preparing for Tamiflu-resistant influenza viruses

December 9, 2013
Researchers in Umeå and Uppsala have found that residues of the influenza drug Tamiflu in our environment can make the influenza virus in birds resistant. This can have serious consequences in the event of an influenza pandemic. ...

Early use of antiviral medications may help prevent lung failure in children with the flu, reduce hospitalizations

November 8, 2012
(Medical Xpress)—Children hospitalized for the flu are much less likely to require breathing support from a mechanical ventilator if they receive antiviral drugs like oseltamivir (Tamiflu) as soon as possible after admission, ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.